Trial Results of Solriamfetol in MDD With/Without Excessive Daytime Sleepiness
May 18, 2025
A new phase 3 proof-of-concept trial offers early evidence that sol...
Read More
Study Demonstrates Success in Shifting Adolescent Sleep Patterns Through Targeted Interventions
March 12, 2025
A recent study examined whether a motivational group-based sleep in...
Read More
FDA Approves Tirzepatide for Adults with Obstructive Sleep Apnea and Obesity
December 21, 2024
The FDA has approved tirzepatide for adults with moderate-to-severe...
Read More
Poor Sleep Associated with Poorer Antidepressant Response
September 23, 2024
Poor sleep is common in treatment-resistant late-life depression an...
Read More
Bright Light Exposure, Depression Symptoms, and Sleep Regularity
August 16, 2024
Bright light therapy is typically used to manage circadian rhythm d...
Read More
Association Between Dual Orexin Receptor Antagonists And Suicidality
July 7, 2024
A recent study explored whether dual orexin receptor antagonists (D...
Read More
FDA Approves Pitolisant for Excessive Daytime Sleepiness in Pediatric Narcolepsy
June 25, 2024
The U.S. Food and Drug Administration has approved a new treatment ...
Read More
Therapies to Reduce Daytime Symptoms of Insomnia
January 24, 2024
Insomnia poses significant challenges to individuals and society du...
Read More
Sleep Therapies to Improve Daytime Cognition
January 18, 2024
The extent to which a person’s cognition is improved after utilizin...
Read More
Combination Treatment of Obstructive Sleep Apnea
December 14, 2023
The primary treatment for obstructive sleep apnea is the CPAP machi...
Read More
How Sleep Loss Amplifies Pain
November 20, 2023
Chronic pain, a pervasive condition affecting 11–40% of adults, is ...
Read More
Sleep Disturbance May Predict Increased Risk of Suicidal Thoughts
September 12, 2023
It is well established, as illustrated in the figure above, that ab...
Read More